These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 20868323)

  • 41. [Regulatory aspect of regenerative medicine/cell therapy: focused on non-clinical studies].
    Matsuyama A
    Rinsho Ketsueki; 2012 Oct; 53(10):1801-7. PubMed ID: 23037754
    [No Abstract]   [Full Text] [Related]  

  • 42. The future of regenerative medicine: urinary system.
    Ludlow JW; Kelley RW; Bertram TA
    Tissue Eng Part B Rev; 2012 Jun; 18(3):218-24. PubMed ID: 22070608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Industrialization of regenerative medicine in Japan].
    Sugawara K; Hata K
    Clin Calcium; 2008 Dec; 18(12):1751-6. PubMed ID: 19043189
    [TBL] [Abstract][Full Text] [Related]  

  • 44. AMP v. Myriad: a surgical strike on Blockbuster business models.
    Gold RE; Cook-Deegan R; Bubela T
    Sci Transl Med; 2013 Jul; 5(192):192ed9. PubMed ID: 23825298
    [No Abstract]   [Full Text] [Related]  

  • 45. Will the nanomedicine "patent land grab" thwart commercialization?
    Bawa R
    Nanomedicine; 2005 Dec; 1(4):346-50. PubMed ID: 17292108
    [No Abstract]   [Full Text] [Related]  

  • 46. In wake of 9/11, drug-patent rules change.
    Cassels A
    CMAJ; 2002 Feb; 166(3):366. PubMed ID: 11868652
    [No Abstract]   [Full Text] [Related]  

  • 47. Commercialization of academic research (patent, publish and flourish).
    Bruce CD
    Theriogenology; 1999 Jan; 51(1):3. PubMed ID: 10729053
    [No Abstract]   [Full Text] [Related]  

  • 48. Business backlash kills off software meeting.
    Butler D
    Nature; 2003 Aug; 424(6952):984. PubMed ID: 12944927
    [No Abstract]   [Full Text] [Related]  

  • 49. Regenerative medicine.
    Banfi G; Corsi MM
    J Biol Regul Homeost Agents; 2011; 25(2 Suppl):S1. PubMed ID: 22051165
    [No Abstract]   [Full Text] [Related]  

  • 50. US trade rules seek to balance health and patent protection.
    Wadman M; Cherry M
    Nature; 1999 Dec; 402(6762):567-8. PubMed ID: 10604448
    [No Abstract]   [Full Text] [Related]  

  • 51. It's all about cures and cash. How the winner of the race to patent human genes may strike it rich.
    Sherrid P
    US News World Rep; 2001 Jan; 130(1):35-6. PubMed ID: 11189705
    [No Abstract]   [Full Text] [Related]  

  • 52. [Regenerative medicine using cell-sheet engineering].
    Kanai N; Yamato M; Ohki T; Yamamoto M; Okano T
    Nihon Geka Gakkai Zasshi; 2012 Sep; 113(5):435-40. PubMed ID: 23061365
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Future aspect of regenerative medicine for cerebral infarction].
    Kitagawa K
    Nihon Rinsho; 2006 Oct; 64 Suppl 7():643-8. PubMed ID: 17461217
    [No Abstract]   [Full Text] [Related]  

  • 54. McGowan Institute for Regenerative Medicine.
    Russell A
    Regen Med; 2010 Jan; 5(1):23-5. PubMed ID: 20017691
    [No Abstract]   [Full Text] [Related]  

  • 55. International patent law-boon or bane of biotech?
    Basu P
    Nat Biotechnol; 2005 Jan; 23(1):13-5. PubMed ID: 15637604
    [No Abstract]   [Full Text] [Related]  

  • 56. Focus on the patent cliff to maximize generic savings.
    Cahn L
    Manag Care; 2012 Nov; 21(11):28-32. PubMed ID: 23236715
    [No Abstract]   [Full Text] [Related]  

  • 57. How should we support pharmaceutical innovation?
    Grootendorst P
    Expert Rev Pharmacoecon Outcomes Res; 2009 Aug; 9(4):313-20. PubMed ID: 19670991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AIDS drugs. Brazil, Thailand override big pharma patents.
    Cohen J
    Science; 2007 May; 316(5826):816. PubMed ID: 17495145
    [No Abstract]   [Full Text] [Related]  

  • 59. Patents and nanomedicine.
    Bawa R
    Nanomedicine (Lond); 2007 Jun; 2(3):351-74. PubMed ID: 17716180
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Commercialization of genes--breast cancer gene patent is a pilot case. Sweden must play a part in the development].
    Olsson H
    Lakartidningen; 1999 Sep; 96(37):3920-3. PubMed ID: 10522102
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.